Salt-wasting congenital adrenal hyperplasia: Genotypical peculiarities in a Sicilian ethnic group

Journal of Endocrinological Investigation

Volumn 31, Issue 7, 2008, Pages 607-609

  Wasniewska, M ^a,d   Caruso, M ^b   Indovina, S ^c   Crisafulli, G ^a   Mirabelli, S ^a   Salzano, G ^a   Arrigo, T ^a   De Luca, F ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c Villa Sofia Hospital   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

Congenital adrenal hyperplasia; Genotypical peculiarities; Salt waste; Sicilian ethnic group

Indexed keywords

CYTIDINE; CYTOCHROME P450 21A2; GUANOSINE; STEROID 21 MONOOXYGENASE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; ETHNIC GROUP; FEMALE; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; ITALY; MALE; MUTATION RATE; PEDIGREE ANALYSIS; POPULATION RESEARCH; SALT WASTING CONGENITAL ADRENAL HYPERPLASIA;

EID: 54949117145     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345610     Document Type: Article

References (19)

1. Wilson RC, Mercado AB, Cheng KC, New MI. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 1995, 80: 2322-9.
2. Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well-defined patients from southern Germany. J Clin Endocrinol Metab 2000, 85: 1059-65.
3. Wilson RC, Nimkam S, Dumic M, et al. Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol Genet Metab 2007, 90: 414-21.
4. Wasniewska M, Di Pasquale G, Rulli I, et al. In Sicilian ethnic group non-classical congenital adrenal hyperplasia is frequently associated with a very mild genotype. J Endocrinol Invest 2007, 30: 181-5.
5. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000, 21: 245-91.
6. Balsamo A, Cacciari E, Baldazzi L, et al. CYP21 analisis and phenotype/ genotype relationship in the screened population of the Italian Emilia-Romagna region. Clin Endocrinol (Oxf) 2000, 53: 117-25.
7. Dolzan V, Sólyom J, Fekete G, et al. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol 2005, 153: 99-106.
8. Dracopoulou-Vabouli M, Maniati-Christidi M, Dacou-Voutetakis C. The spectrum of molecular defects of the CYP21 Gene in the Hellenic population: variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001, 86: 2845-8.
9. Grigorescu Sido A, Weber MM, Grigorescu Sido P, Clausmeyer S, Heinrich U, Schulze E. 21-hydroxylase and 11β-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2005, 90: 5769-73.
10. Pinto G, Tardy V, Trivin C, et al. Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydrxylase deficiency: relevance of genotype for management. J Clin Endocrinol Metab 2003, 88: 2624-33.
11. Stikkelbroeck NM, Hoefsloot LH, De Wijs IJ, Often BJ, Hermus AR, Sistermans EA. CYP21 gene mutation analysis in 198 patients with 21-hydroxlase deficiency in the Netherlands: six novel mutations ad a specific cluster of four mutations. J Clin Endocrinol Metab 2003, 88: 3852-9.
12. Kharrat M, Tardy V, M'Rad R, et al. Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation. J Clin Endocrinol Metab 2004, 89: 368-74.
13. Vakili R, Baradaran-Heravi A, Barid-Fatehi B, Gholamin M, Ghaemi N, Abbaszadegan MR. Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21-hydroxylase deficiency in northeastern Iran. Horm Res 2005, 63: 119-24.
14. Di Pasquale G, Wasniewska M, Caruso M, et al. Salt wasting phenotype in a compound heterozygous girl with P482S mutation associated with a novel mutation of CYP21 gene (Q481P). J Endocrinol Invest 2005, 28: 1038-9.
15. Di Pasquale L, Indovina S, Wasniewska M, et al. Novel nonsense mutation (W22X) in CYP21A2 gene causing salt-wasting congenital adrenal hyperplasia in a compound heterozygous girl. J Endocrinol Invest 2007, 30: 806-7.
16. Barbaro M, Lajic S, Baldazzi L, et al. Functional analysis of two recurrent amino acid substitutions in the CYP21gene from Italian patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2004, 89: 2402-7.
17. Lajic S, Wedell A. An intron 1 splice mutation and a nonsense mutation (W23X) in CYP21 causing severe congenital adrenal hyperplasia. Hum Genet 1996, 98: 182-4.
18. Porzio O, Cunsolo V, Malaponti M, et al. Divergent phenotype of two siblings human leukocyte antigen identical, affected by non-classical and classical congenital adrenal hyperplasia caused by 21-hydroxylas deficiency. J Clin Endocrinol Metab 2006, 91: 4510-3.
19. López-Gutiérrez AU, Riba L, Ordoñez-Sánchez ML, Ramírez-Jiménez S, Cerrillo-Hinojosa M, Tusié-Luna MT. Uniparental disomy for chromosome 6 results in steroid 21-hydroxylase deficiency: evidence of different genetic mechanisms involved in the production of the disease. J Med Genet 1998, 35: 1014-9.